3 resultados para peripheral venous catheters
em Archivo Digital para la Docencia y la Investigación - Repositorio Institucional de la Universidad del País Vasco
Resumo:
[ES]Los cateterismos venosos periféricos son los dispositivos que con mayor frecuencia se emplean en el acceso vascular para pacientes que se encuentran ingresados en unidades hospitalarias. Estos catéteres son reemplazados sistemáticamente cada tres o cuatro días para tratar de prevenir la flebitis como refleja la guía de Center for Disease control and prevention (CDC) y por extensión, nuestro sistema de salud de Osakidetza. Sin embargo, la evidencia que apoya esta práctica no está del todo cimentada.El objetivo de esta revisión bibliográfica es evaluar la efectividad de esta práctica clínica tan integrada en la vida diaria de los profesionales de enfermería mediante la evaluación de la evidencia científica existente hasta el momento.Se realizo una búsqueda exhaustiva en diferentes bases de datos electrónicas desde Octubre de 2012 hasta Abril del año 2013. Se descargaron los textos completos de aquellos artículos que pudiesen ser potencialmente útiles en el estudio y se analizaron bajo los criterios de inclusión y selección. Los siete artículos seleccionados como válidos no demuestran que sea necesario sustituir de forma sistemática el catéter venoso periférico así como lo defiende la CDC. Debido a ello, se podría abolir esta práctica clínica que reduciría significativamente el dolor y las molestias que sufren los pacientes día a día, el tiempo que el personal de enfermería dedica en este tipo de prácticas, además de todo el coste sanitario que ello con lleva.
Resumo:
INTRODUCTION: MicroRNAs (miRNAs) are being increasingly studied in relation to energy metabolism and body composition homeostasis. Indeed, the quantitative analysis of miRNAs expression in different adiposity conditions may contribute to understand the intimate mechanisms participating in body weight control and to find new biomarkers with diagnostic or prognostic value in obesity management. OBJECTIVE: The aim of this study was the search for miRNAs in blood cells whose expression could be used as prognostic biomarkers of weight loss. METHODS: Ten Caucasian obese women were selected among the participants in a weight-loss trial that consisted in following an energy-restricted treatment. Weight loss was considered unsuccessful when <5% of initial body weight (non-responders) and successful when >5% (responders). At baseline, total miRNA isolated from peripheral blood mononuclear cells (PBMC) was sequenced with SOLiD v4. The miRNA sequencing data were validated by RT-PCR. RESULTS: Differential baseline expression of several miRNAs was found between responders and non-responders. Two miRNAs were up-regulated in the non-responder group (mir-935 and mir-4772) and three others were down-regulated (mir-223, mir-224 and mir-376b). Both mir-935 and mir-4772 showed relevant associations with the magnitude of weight loss, although the expression of other transcripts (mir-874, mir-199b, mir-766, mir-589 and mir-148b) also correlated with weight loss. CONCLUSIONS: This research addresses the use of high-throughput sequencing technologies in the search for miRNA expression biomarkers in obesity, by determining the miRNA transcriptome of PBMC. Basal expression of different miRNAs, particularly mir-935 and mir-4772, could be prognostic biomarkers and may forecast the response to a hypocaloric diet.
Resumo:
Background: Vitamin K has been related to glucose metabolism, insulin sensitivity and diabetes. Because inflammation underlies all these metabolic conditions, it is plausible that the potential role of vitamin K in glucose metabolism occurs through the modulation of cytokines and related molecules. The purpose of the study was to assess the associations between dietary intake of vitamin K and peripheral adipokines and other metabolic risk markers related to insulin resistance and type 2 diabetes mellitus. Methods: Cross-sectional and longitudinal assessments of these associations in 510 elderly participants recruited in the PREDIMED centers of Reus and Barcelona (Spain). We determined 1-year changes in dietary phylloquinone intake estimated by food frequency questionnaires, serum inflammatory cytokines and other metabolic risk markers. Results: In the cross-sectional analysis at baseline no significant associations were found between dietary phylloquinone intake and the rest of metabolic risk markers evaluated, with exception of a negative association with plasminogen activator inhibitor-1. After 1-year of follow-up, subjects in the upper tertile of changes in dietary phylloquinone intake showed a greater reduction in ghrelin (-15.0%), glucose-dependent insulinotropic peptide (-12.9%), glucagon-like peptide-1 (-17.6%), IL-6 (-27.9%), leptin (-10.3%), TNF (-26.9%) and visfatin (-24.9%) plasma concentrations than those in the lowest tertile (all p<0.05). Conclusion: These results show that dietary phylloquinone intake is associated with an improvement of cytokines and other markers related to insulin resistance and diabetes, thus extending the potential protection by dietary phylloquinone on chronic inflammatory diseases.